Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sepsis | 13 | 2024 | 2593 | 1.550 |
Why?
|
Hypothermia, Induced | 5 | 2022 | 752 | 1.400 |
Why?
|
Out-of-Hospital Cardiac Arrest | 4 | 2022 | 339 | 1.370 |
Why?
|
Acute Lung Injury | 11 | 2022 | 380 | 1.280 |
Why?
|
Respiration, Artificial | 20 | 2022 | 2569 | 1.200 |
Why?
|
Shock, Septic | 10 | 2022 | 775 | 1.180 |
Why?
|
Intensive Care Units | 22 | 2024 | 3680 | 1.080 |
Why?
|
Hospital Mortality | 20 | 2021 | 5316 | 0.880 |
Why?
|
Fluid Therapy | 5 | 2023 | 593 | 0.840 |
Why?
|
Respiratory Insufficiency | 5 | 2023 | 1199 | 0.820 |
Why?
|
Resuscitation | 6 | 2020 | 658 | 0.770 |
Why?
|
Emergency Medicine | 2 | 2019 | 1205 | 0.700 |
Why?
|
Calcitonin | 2 | 2018 | 336 | 0.690 |
Why?
|
Positive-Pressure Respiration | 7 | 2022 | 633 | 0.680 |
Why?
|
Emergency Service, Hospital | 14 | 2019 | 7658 | 0.670 |
Why?
|
Theophylline | 1 | 2017 | 132 | 0.580 |
Why?
|
Survivors | 3 | 2022 | 2291 | 0.570 |
Why?
|
Benzamides | 1 | 2022 | 1379 | 0.560 |
Why?
|
Pyrazines | 1 | 2022 | 1230 | 0.540 |
Why?
|
Respiratory Tract Infections | 3 | 2018 | 961 | 0.540 |
Why?
|
Heart Arrest | 3 | 2022 | 1470 | 0.520 |
Why?
|
Adrenal Cortex Hormones | 5 | 2020 | 1856 | 0.490 |
Why?
|
Thiamine | 3 | 2020 | 152 | 0.490 |
Why?
|
Cardiac Output | 1 | 2016 | 854 | 0.470 |
Why?
|
Bronchodilator Agents | 1 | 2017 | 502 | 0.460 |
Why?
|
Developed Countries | 2 | 2021 | 437 | 0.450 |
Why?
|
Protein Precursors | 1 | 2017 | 1154 | 0.440 |
Why?
|
Middle Aged | 73 | 2024 | 213390 | 0.440 |
Why?
|
Urinary Catheterization | 1 | 2014 | 202 | 0.440 |
Why?
|
Acute Kidney Injury | 6 | 2022 | 1968 | 0.440 |
Why?
|
Aged | 61 | 2024 | 163288 | 0.430 |
Why?
|
Ascorbic Acid | 3 | 2020 | 651 | 0.410 |
Why?
|
Shock | 3 | 2020 | 318 | 0.410 |
Why?
|
Catheter-Related Infections | 2 | 2014 | 252 | 0.400 |
Why?
|
Health Care Reform | 2 | 2019 | 1261 | 0.380 |
Why?
|
Tidal Volume | 4 | 2021 | 490 | 0.380 |
Why?
|
Critical Illness | 7 | 2021 | 2670 | 0.370 |
Why?
|
Male | 79 | 2024 | 350115 | 0.370 |
Why?
|
Patient Admission | 2 | 2017 | 1380 | 0.360 |
Why?
|
Female | 79 | 2024 | 380193 | 0.350 |
Why?
|
Hyperbaric Oxygenation | 1 | 2020 | 163 | 0.340 |
Why?
|
Prospective Studies | 32 | 2023 | 53290 | 0.330 |
Why?
|
Taiwan | 4 | 2018 | 496 | 0.330 |
Why?
|
Aspirin | 4 | 2021 | 3283 | 0.320 |
Why?
|
Atracurium | 2 | 2019 | 52 | 0.320 |
Why?
|
Vasoconstrictor Agents | 5 | 2023 | 642 | 0.320 |
Why?
|
Humans | 105 | 2024 | 744366 | 0.310 |
Why?
|
Platelet Aggregation Inhibitors | 4 | 2021 | 3070 | 0.310 |
Why?
|
Antibodies, Neutralizing | 3 | 2021 | 1978 | 0.300 |
Why?
|
Developing Countries | 3 | 2021 | 2815 | 0.300 |
Why?
|
Adult | 49 | 2024 | 214052 | 0.290 |
Why?
|
Neuromuscular Blocking Agents | 2 | 2019 | 130 | 0.290 |
Why?
|
Oxygen | 3 | 2023 | 4189 | 0.290 |
Why?
|
Ventilator-Induced Lung Injury | 2 | 2021 | 122 | 0.280 |
Why?
|
Cross Infection | 3 | 2020 | 1417 | 0.280 |
Why?
|
Neuromuscular Blockade | 4 | 2021 | 146 | 0.280 |
Why?
|
Cardiopulmonary Resuscitation | 4 | 2022 | 980 | 0.270 |
Why?
|
Catheterization, Central Venous | 1 | 2010 | 514 | 0.270 |
Why?
|
Blood Gas Analysis | 2 | 2017 | 383 | 0.260 |
Why?
|
Cholecalciferol | 2 | 2021 | 535 | 0.260 |
Why?
|
Severity of Illness Index | 12 | 2021 | 15535 | 0.250 |
Why?
|
Body Mass Index | 3 | 2021 | 12721 | 0.250 |
Why?
|
Anti-Bacterial Agents | 5 | 2022 | 7182 | 0.250 |
Why?
|
Tracheostomy | 1 | 2018 | 401 | 0.250 |
Why?
|
Angiotensin II | 2 | 2018 | 881 | 0.240 |
Why?
|
Aged, 80 and over | 15 | 2021 | 57776 | 0.240 |
Why?
|
Quality of Health Care | 2 | 2021 | 4369 | 0.240 |
Why?
|
Endothelial Cells | 1 | 2017 | 3486 | 0.240 |
Why?
|
Physical Exertion | 2 | 2017 | 695 | 0.230 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2017 | 3047 | 0.230 |
Why?
|
Double-Blind Method | 9 | 2022 | 12025 | 0.230 |
Why?
|
Practice Guidelines as Topic | 5 | 2021 | 7282 | 0.230 |
Why?
|
Clinical Protocols | 3 | 2021 | 1461 | 0.220 |
Why?
|
Multicenter Studies as Topic | 2 | 2019 | 1677 | 0.220 |
Why?
|
Immunocompromised Host | 1 | 2018 | 847 | 0.220 |
Why?
|
Adenosine Monophosphate | 2 | 2021 | 275 | 0.220 |
Why?
|
Alanine | 2 | 2021 | 572 | 0.210 |
Why?
|
Ticlopidine | 1 | 2018 | 899 | 0.210 |
Why?
|
Ischemic Attack, Transient | 1 | 2018 | 935 | 0.210 |
Why?
|
Hospitalization | 11 | 2023 | 10259 | 0.200 |
Why?
|
Lung Injury | 2 | 2017 | 436 | 0.200 |
Why?
|
Renin | 1 | 2024 | 642 | 0.200 |
Why?
|
Treatment Outcome | 17 | 2023 | 63107 | 0.200 |
Why?
|
Microcirculation | 2 | 2018 | 1287 | 0.200 |
Why?
|
Patient Discharge | 3 | 2023 | 3318 | 0.200 |
Why?
|
Secondary Prevention | 1 | 2018 | 1530 | 0.200 |
Why?
|
Pneumonia | 3 | 2019 | 2133 | 0.200 |
Why?
|
Logistic Models | 7 | 2021 | 13409 | 0.190 |
Why?
|
Propensity Score | 4 | 2018 | 1781 | 0.190 |
Why?
|
Mortality | 2 | 2021 | 2864 | 0.190 |
Why?
|
Risk Factors | 22 | 2022 | 72296 | 0.190 |
Why?
|
Vitamin D Deficiency | 2 | 2021 | 1343 | 0.190 |
Why?
|
Hypotension | 3 | 2023 | 884 | 0.180 |
Why?
|
Treatment Failure | 6 | 2021 | 2618 | 0.180 |
Why?
|
Amiodarone | 1 | 2012 | 212 | 0.180 |
Why?
|
Health Personnel | 3 | 2024 | 3219 | 0.180 |
Why?
|
Immunocompetence | 1 | 2019 | 136 | 0.170 |
Why?
|
Cohort Studies | 17 | 2023 | 40559 | 0.170 |
Why?
|
Guideline Adherence | 2 | 2021 | 2265 | 0.170 |
Why?
|
Renal Replacement Therapy | 2 | 2018 | 257 | 0.160 |
Why?
|
Antiviral Agents | 2 | 2021 | 2987 | 0.160 |
Why?
|
Indonesia | 1 | 2018 | 119 | 0.160 |
Why?
|
Retrospective Studies | 17 | 2022 | 77460 | 0.160 |
Why?
|
Health Status Indicators | 1 | 2013 | 970 | 0.160 |
Why?
|
Defibrillators | 1 | 2018 | 37 | 0.160 |
Why?
|
Outpatients | 2 | 2022 | 1487 | 0.160 |
Why?
|
Multiple Organ Failure | 1 | 2020 | 389 | 0.150 |
Why?
|
Trauma, Nervous System | 1 | 2017 | 36 | 0.150 |
Why?
|
Heat Stroke | 1 | 2017 | 31 | 0.150 |
Why?
|
APACHE | 4 | 2021 | 277 | 0.150 |
Why?
|
Sex Factors | 4 | 2013 | 10400 | 0.150 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2012 | 789 | 0.150 |
Why?
|
Drug Therapy, Combination | 6 | 2021 | 6489 | 0.150 |
Why?
|
Civil Defense | 1 | 2018 | 109 | 0.140 |
Why?
|
Pyridones | 1 | 2021 | 711 | 0.140 |
Why?
|
Hydroxychloroquine | 1 | 2020 | 412 | 0.140 |
Why?
|
China | 2 | 2019 | 2245 | 0.140 |
Why?
|
Critical Care | 3 | 2019 | 2647 | 0.140 |
Why?
|
Glucocorticoids | 3 | 2021 | 2108 | 0.140 |
Why?
|
Thrombomodulin | 1 | 2017 | 102 | 0.140 |
Why?
|
Venous Thrombosis | 2 | 2023 | 1239 | 0.140 |
Why?
|
Monitoring, Physiologic | 2 | 2016 | 1739 | 0.140 |
Why?
|
Oximetry | 2 | 2017 | 471 | 0.140 |
Why?
|
Angiopoietin-2 | 1 | 2017 | 172 | 0.140 |
Why?
|
Inappropriate Prescribing | 1 | 2018 | 202 | 0.130 |
Why?
|
Inflammation | 4 | 2023 | 10637 | 0.130 |
Why?
|
C-Reactive Protein | 3 | 2022 | 3778 | 0.130 |
Why?
|
Erythrocyte Indices | 1 | 2016 | 146 | 0.130 |
Why?
|
Creatinine | 3 | 2022 | 1919 | 0.130 |
Why?
|
Urine | 1 | 2017 | 370 | 0.130 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2017 | 306 | 0.130 |
Why?
|
Triage | 2 | 2020 | 977 | 0.130 |
Why?
|
Hydrocortisone | 2 | 2019 | 1826 | 0.120 |
Why?
|
Delivery of Health Care | 4 | 2023 | 5321 | 0.120 |
Why?
|
Permeability | 1 | 2017 | 738 | 0.120 |
Why?
|
Sputum | 1 | 2017 | 476 | 0.120 |
Why?
|
Odds Ratio | 4 | 2019 | 9849 | 0.120 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 738 | 0.120 |
Why?
|
Erythrocyte Transfusion | 2 | 2017 | 565 | 0.120 |
Why?
|
Vitamins | 2 | 2021 | 1623 | 0.120 |
Why?
|
Blood | 1 | 2017 | 598 | 0.120 |
Why?
|
Hemostasis | 1 | 2017 | 458 | 0.120 |
Why?
|
Lactic Acid | 2 | 2016 | 1132 | 0.120 |
Why?
|
Fever | 2 | 2018 | 1616 | 0.120 |
Why?
|
Cerebral Hemorrhage | 2 | 2017 | 2647 | 0.120 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2017 | 552 | 0.120 |
Why?
|
History, 21st Century | 1 | 2019 | 1534 | 0.110 |
Why?
|
United States | 13 | 2023 | 69872 | 0.110 |
Why?
|
Stroke | 2 | 2023 | 9981 | 0.110 |
Why?
|
Unnecessary Procedures | 1 | 2017 | 432 | 0.110 |
Why?
|
Databases, Factual | 1 | 2018 | 7730 | 0.110 |
Why?
|
Internationality | 2 | 2019 | 1002 | 0.110 |
Why?
|
von Willebrand Factor | 1 | 2017 | 669 | 0.110 |
Why?
|
Time Factors | 8 | 2023 | 40075 | 0.110 |
Why?
|
Bacterial Infections | 2 | 2018 | 1401 | 0.110 |
Why?
|
Occupational Diseases | 1 | 2021 | 1469 | 0.110 |
Why?
|
Prone Position | 2 | 2021 | 194 | 0.110 |
Why?
|
Waist Circumference | 1 | 2016 | 917 | 0.110 |
Why?
|
Mesenchymal Stem Cells | 1 | 2023 | 1632 | 0.100 |
Why?
|
Executive Function | 1 | 2021 | 1364 | 0.100 |
Why?
|
Workload | 1 | 2018 | 849 | 0.100 |
Why?
|
Kaplan-Meier Estimate | 3 | 2021 | 6539 | 0.100 |
Why?
|
Virus Diseases | 1 | 2018 | 711 | 0.100 |
Why?
|
Hyperglycemia | 2 | 2020 | 1373 | 0.100 |
Why?
|
History, 20th Century | 1 | 2019 | 2740 | 0.100 |
Why?
|
Central Nervous System | 1 | 2019 | 1357 | 0.100 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2018 | 1115 | 0.100 |
Why?
|
Young Adult | 10 | 2021 | 56429 | 0.100 |
Why?
|
Length of Stay | 4 | 2021 | 6311 | 0.100 |
Why?
|
Life Support Systems | 1 | 2010 | 11 | 0.100 |
Why?
|
Pyrazoles | 1 | 2021 | 1972 | 0.100 |
Why?
|
Patient Positioning | 2 | 2021 | 324 | 0.100 |
Why?
|
Running | 1 | 2015 | 480 | 0.090 |
Why?
|
Health Care Surveys | 2 | 2018 | 2453 | 0.090 |
Why?
|
Cytokines | 2 | 2023 | 7323 | 0.090 |
Why?
|
Partial Pressure | 2 | 2016 | 254 | 0.090 |
Why?
|
Comorbidity | 5 | 2019 | 10388 | 0.090 |
Why?
|
Tissue Plasminogen Activator | 1 | 2017 | 1261 | 0.090 |
Why?
|
Leukocytes | 1 | 2018 | 2045 | 0.090 |
Why?
|
Lipopolysaccharides | 1 | 2018 | 2216 | 0.090 |
Why?
|
Statistics as Topic | 1 | 2017 | 2373 | 0.090 |
Why?
|
ROC Curve | 4 | 2020 | 3528 | 0.090 |
Why?
|
Hypoxia, Brain | 1 | 2010 | 133 | 0.090 |
Why?
|
Prognosis | 4 | 2024 | 29060 | 0.090 |
Why?
|
Uric Acid | 1 | 2015 | 766 | 0.090 |
Why?
|
Age Factors | 3 | 2016 | 18373 | 0.090 |
Why?
|
Adolescent | 8 | 2021 | 85779 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2022 | 9955 | 0.080 |
Why?
|
Health Services Research | 1 | 2016 | 1836 | 0.080 |
Why?
|
Area Under Curve | 3 | 2020 | 1655 | 0.080 |
Why?
|
Triglycerides | 1 | 2016 | 2453 | 0.080 |
Why?
|
Early Diagnosis | 3 | 2015 | 1184 | 0.080 |
Why?
|
Prevalence | 4 | 2020 | 15221 | 0.080 |
Why?
|
Income | 1 | 2017 | 1913 | 0.080 |
Why?
|
Confidence Intervals | 1 | 2014 | 2971 | 0.080 |
Why?
|
Thrombosis | 1 | 2021 | 2968 | 0.080 |
Why?
|
Clinical Trials as Topic | 2 | 2021 | 7914 | 0.070 |
Why?
|
Administration, Inhalation | 2 | 2014 | 1105 | 0.070 |
Why?
|
Cross-Sectional Studies | 5 | 2024 | 25039 | 0.070 |
Why?
|
Wounds and Injuries | 1 | 2019 | 2400 | 0.070 |
Why?
|
Emergency Medical Services | 1 | 2018 | 1917 | 0.070 |
Why?
|
Health Services Needs and Demand | 1 | 2014 | 1410 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2017 | 3511 | 0.070 |
Why?
|
Blood Glucose | 2 | 2018 | 6254 | 0.070 |
Why?
|
Family | 1 | 2016 | 3147 | 0.070 |
Why?
|
Incidence | 5 | 2019 | 20952 | 0.060 |
Why?
|
Carbon Dioxide | 1 | 2019 | 1150 | 0.060 |
Why?
|
Acute Disease | 3 | 2019 | 7147 | 0.060 |
Why?
|
Antibodies, Monoclonal | 1 | 2021 | 9274 | 0.060 |
Why?
|
Diabetes Mellitus | 2 | 2018 | 5749 | 0.060 |
Why?
|
Mass Screening | 1 | 2020 | 5253 | 0.060 |
Why?
|
Glucose | 1 | 2016 | 4398 | 0.060 |
Why?
|
Electrocardiography | 1 | 2017 | 6442 | 0.060 |
Why?
|
Vaccines, Combined | 1 | 2023 | 69 | 0.060 |
Why?
|
Cognition | 1 | 2021 | 6770 | 0.060 |
Why?
|
Decision Making | 1 | 2017 | 3888 | 0.060 |
Why?
|
Stroke Volume | 1 | 2016 | 5006 | 0.060 |
Why?
|
Hemorrhage | 2 | 2021 | 3461 | 0.060 |
Why?
|
Pediatrics | 1 | 2018 | 3475 | 0.060 |
Why?
|
Mental Recall | 2 | 2021 | 1206 | 0.050 |
Why?
|
Infusions, Intravenous | 2 | 2018 | 2274 | 0.050 |
Why?
|
Case-Control Studies | 4 | 2023 | 21748 | 0.050 |
Why?
|
Nucleocapsid | 1 | 2022 | 59 | 0.050 |
Why?
|
Remission Induction | 1 | 2018 | 2385 | 0.050 |
Why?
|
Cardiotonic Agents | 2 | 2017 | 535 | 0.050 |
Why?
|
Blood Urea Nitrogen | 1 | 2022 | 191 | 0.050 |
Why?
|
Statistics, Nonparametric | 1 | 2018 | 2887 | 0.050 |
Why?
|
Tissue Inhibitor of Metalloproteinase-2 | 1 | 2022 | 68 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3135 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3242 | 0.050 |
Why?
|
Early Termination of Clinical Trials | 1 | 2021 | 68 | 0.050 |
Why?
|
Glomerular Filtration Rate | 1 | 2019 | 2166 | 0.050 |
Why?
|
Pulse Therapy, Drug | 1 | 2021 | 35 | 0.050 |
Why?
|
Research Design | 1 | 2017 | 5984 | 0.050 |
Why?
|
Blood Pressure | 1 | 2017 | 8551 | 0.050 |
Why?
|
Multivariate Analysis | 4 | 2017 | 12244 | 0.050 |
Why?
|
Diabetes Complications | 1 | 2018 | 1359 | 0.050 |
Why?
|
Risk | 2 | 2018 | 9688 | 0.050 |
Why?
|
Medical Futility | 1 | 2021 | 127 | 0.050 |
Why?
|
Combined Modality Therapy | 3 | 2019 | 8642 | 0.050 |
Why?
|
Immunization Schedule | 1 | 2021 | 221 | 0.040 |
Why?
|
Hypernatremia | 1 | 2020 | 82 | 0.040 |
Why?
|
Physicians | 1 | 2018 | 4567 | 0.040 |
Why?
|
Survival Rate | 3 | 2019 | 12788 | 0.040 |
Why?
|
Intention to Treat Analysis | 1 | 2020 | 426 | 0.040 |
Why?
|
Tidal Waves | 1 | 2019 | 3 | 0.040 |
Why?
|
Immunization, Secondary | 1 | 2021 | 340 | 0.040 |
Why?
|
Ischemia | 1 | 2018 | 1907 | 0.040 |
Why?
|
Lung | 2 | 2023 | 9857 | 0.040 |
Why?
|
Systemic Inflammatory Response Syndrome | 2 | 2014 | 612 | 0.040 |
Why?
|
Microscopy, Video | 1 | 2018 | 245 | 0.040 |
Why?
|
Quarantine | 1 | 2020 | 170 | 0.040 |
Why?
|
Feasibility Studies | 2 | 2019 | 5077 | 0.040 |
Why?
|
Respiratory Rate | 1 | 2019 | 162 | 0.040 |
Why?
|
Antigens, Viral | 1 | 2021 | 1035 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2014 | 15078 | 0.040 |
Why?
|
Vasodilator Agents | 1 | 2021 | 976 | 0.040 |
Why?
|
Ventilators, Mechanical | 1 | 2019 | 292 | 0.040 |
Why?
|
Aftercare | 1 | 2023 | 870 | 0.040 |
Why?
|
Delayed Diagnosis | 1 | 2020 | 441 | 0.040 |
Why?
|
Catecholamines | 1 | 2017 | 387 | 0.030 |
Why?
|
Cause of Death | 2 | 2017 | 3582 | 0.030 |
Why?
|
Risk Adjustment | 1 | 2020 | 594 | 0.030 |
Why?
|
Heat Exhaustion | 1 | 2015 | 13 | 0.030 |
Why?
|
Glasgow Coma Scale | 1 | 2017 | 570 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2016 | 19905 | 0.030 |
Why?
|
Disease Progression | 2 | 2018 | 13286 | 0.030 |
Why?
|
Chi-Square Distribution | 1 | 2021 | 3508 | 0.030 |
Why?
|
Conscious Sedation | 1 | 2019 | 528 | 0.030 |
Why?
|
Drug Combinations | 1 | 2019 | 1958 | 0.030 |
Why?
|
Job Satisfaction | 1 | 2018 | 534 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2023 | 2133 | 0.030 |
Why?
|
Rhabdomyolysis | 1 | 2015 | 150 | 0.030 |
Why?
|
Rats, Wistar | 1 | 2018 | 1892 | 0.030 |
Why?
|
Hospitals, University | 1 | 2016 | 570 | 0.030 |
Why?
|
Brain Ischemia | 1 | 2018 | 3265 | 0.030 |
Why?
|
Hospitalists | 1 | 2018 | 305 | 0.030 |
Why?
|
Dehydration | 1 | 2015 | 233 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 2022 | 3773 | 0.030 |
Why?
|
Nonlinear Dynamics | 1 | 2016 | 502 | 0.030 |
Why?
|
RNA, Viral | 1 | 2021 | 2901 | 0.030 |
Why?
|
Physical Endurance | 1 | 2015 | 370 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2020 | 12356 | 0.030 |
Why?
|
Muscle Strength | 1 | 2017 | 592 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2016 | 11726 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 1 | 2018 | 783 | 0.030 |
Why?
|
Hyperuricemia | 1 | 2015 | 211 | 0.030 |
Why?
|
Guidelines as Topic | 1 | 2019 | 1405 | 0.030 |
Why?
|
Water-Electrolyte Balance | 1 | 2013 | 346 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2018 | 14723 | 0.030 |
Why?
|
Body Weight | 1 | 2013 | 4671 | 0.030 |
Why?
|
Respiration | 1 | 2019 | 1653 | 0.030 |
Why?
|
Pandemics | 2 | 2024 | 8385 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2021 | 6171 | 0.030 |
Why?
|
Ambulatory Care Facilities | 1 | 2018 | 934 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2014 | 15297 | 0.030 |
Why?
|
Cell Adhesion | 1 | 2018 | 3144 | 0.030 |
Why?
|
Prediabetic State | 1 | 2016 | 499 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2020 | 6366 | 0.020 |
Why?
|
Vaccination | 1 | 2023 | 3279 | 0.020 |
Why?
|
Quality-Adjusted Life Years | 1 | 2017 | 1683 | 0.020 |
Why?
|
Europe | 1 | 2017 | 3338 | 0.020 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2021 | 1354 | 0.020 |
Why?
|
Plasma | 1 | 2013 | 575 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 2014 | 1423 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2019 | 39052 | 0.020 |
Why?
|
Health Status | 1 | 2013 | 4034 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2021 | 10943 | 0.020 |
Why?
|
Hospitals | 1 | 2022 | 3954 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2023 | 13035 | 0.020 |
Why?
|
Hemodynamics | 1 | 2018 | 4196 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2021 | 6994 | 0.020 |
Why?
|
Anticoagulants | 1 | 2023 | 4600 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2011 | 7785 | 0.020 |
Why?
|
Athletes | 1 | 2015 | 1093 | 0.020 |
Why?
|
Child | 3 | 2022 | 77709 | 0.020 |
Why?
|
Blood Transfusion | 1 | 2014 | 1301 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2017 | 2716 | 0.020 |
Why?
|
Public Health | 1 | 2020 | 2602 | 0.020 |
Why?
|
Coma | 1 | 2010 | 475 | 0.020 |
Why?
|
Myocardial Infarction | 1 | 2018 | 11718 | 0.020 |
Why?
|
Evidence-Based Practice | 1 | 2010 | 501 | 0.020 |
Why?
|
Regression Analysis | 1 | 2016 | 6459 | 0.020 |
Why?
|
Vitamin D | 1 | 2019 | 3224 | 0.020 |
Why?
|
Kidney | 1 | 2021 | 7184 | 0.020 |
Why?
|
Algorithms | 1 | 2016 | 13882 | 0.020 |
Why?
|
Patient Readmission | 1 | 2019 | 3116 | 0.020 |
Why?
|
Asthma | 1 | 2014 | 6010 | 0.020 |
Why?
|
Health Care Costs | 1 | 2018 | 3208 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2010 | 950 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2017 | 5388 | 0.010 |
Why?
|
Survival Analysis | 1 | 2017 | 10252 | 0.010 |
Why?
|
Communication | 1 | 2017 | 3750 | 0.010 |
Why?
|
Linear Models | 1 | 2014 | 5953 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2023 | 25628 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9312 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 12961 | 0.010 |
Why?
|
Models, Biological | 1 | 2018 | 9584 | 0.010 |
Why?
|
Quality of Life | 1 | 2023 | 12802 | 0.010 |
Why?
|
Rats | 1 | 2018 | 24252 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2018 | 18034 | 0.010 |
Why?
|
Cardiac Surgical Procedures | 1 | 2014 | 3537 | 0.010 |
Why?
|
Patient Selection | 1 | 2010 | 4216 | 0.010 |
Why?
|
Child, Preschool | 1 | 2018 | 41005 | 0.010 |
Why?
|
Obesity | 1 | 2013 | 12746 | 0.010 |
Why?
|
Animals | 1 | 2018 | 168768 | 0.000 |
Why?
|